The latest closing stock price for Adaptimmune Therapeutics as of February 21, 2025 is 0.56.
An investor who bought $1,000 worth of Adaptimmune Therapeutics stock at the IPO in 2015 would have $-965 today, roughly -1 times their original investment - a -28.49% compound annual growth rate over 10 years.
The all-time high Adaptimmune Therapeutics stock closing price was 21.12 on June 16, 2015.
The Adaptimmune Therapeutics 52-week high stock price is 2.05, which is 266.1% above the current share price.
The Adaptimmune Therapeutics 52-week low stock price is 0.53, which is 5.4% below the current share price.
The average Adaptimmune Therapeutics stock price for the last 52 weeks is 0.99.
An investor who bought $1,000 worth of Adaptimmune Therapeutics stock at the IPO in 2015 would have $-965 today, roughly -1 times their original investment - a -28.49% compound annual growth rate over 10 years.
The all-time high Adaptimmune Therapeutics stock closing price was 21.12 on June 16, 2015.
The Adaptimmune Therapeutics 52-week high stock price is 2.05, which is 266.1% above the current share price.
The Adaptimmune Therapeutics 52-week low stock price is 0.53, which is 5.4% below the current share price.
The average Adaptimmune Therapeutics stock price for the last 52 weeks is 0.99.